| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |